Women aged 30 could be offered breast cancer checks in NHS trial
- An NHS trial based in Manchester is offering breast cancer risk evaluations to women aged 30 to 39, led by the consultant who previously treated Girls Aloud’s Sarah Harding.
- The trial follows Sarah Harding’s death from breast cancer in 2021 and aims to identify younger women at increased risk who currently fall outside routine screening age.
- The study combines mammograms, DNA tests, and questionnaires to calculate risk scores, finding about 19% of 548 women analyzed at elevated risk comparable to women aged 50 and over.
- Girls Aloud bandmates expressed their pride in the study conducted in Sarah Harding’s memory, highlighting its important role in detecting women without symptoms who may benefit from early preventative care.
- Plans are underway to expand the trial nationwide, supporting a national cancer plan to improve early diagnosis and possibly lower screening age from 50 to 30.
7 Articles
7 Articles
Breast cancer survivor shares story of finding love on her road to recovery
WESTLAKE, Ohio (WJW) - In just five minutes of sitting with Marissa Coreno, she feels like a lifelong friend. And once you hear her story, you’ll understand why. At 27 years old, Marissa was living life to the fullest. “I moved to Westlake in my mid-20s, got a job at the Cleveland Clinic,” she said. But it was at work that life suddenly shifted. “I was actually at work at the time and I was cold, so I could put my arms like this and I felt somet…
Women aged 30 to get breast cancer checks in trial led by Sarah Harding's doctor
WOMEN aged 30 will get breast cancer checks in a trial led by the doctor who treated Girls Aloud star Sarah Harding. An NHS study set up in the singer’s name has been expanded after tests shed more light on the risk posed to younger women. AlamySinger Sarah Harding died in 2021 aged 39[/caption] It showed that nearly one in five in their 30s — 19 per cent — face an increased threat. Those taking part will be offered a mammogram scan or DNA analy…
Coverage Details
Bias Distribution
- 67% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage